Court: Vaccine Makers Not Immune from Thimerosal Design Defect Claim
October 9, 2008
DOCUMENTS
- Opinion
ATLANTA - A state Supreme Court has allowed design defect claims to proceed against the manufacturer of a vaccine that allegedly caused a child's thimerosal-related neurological injury. American Home Products Corp., et al. v. Ferrari, et al., No. S07G1708 (Ga. Sup. Ct.).
In an Oct. 6 decision, the Georgia Supreme Court held that Marcelo and Carolyn Ferrari's claims are not preempted by federal law requiring vaccine injury claims to first be pursued through a no-fault compensation system established by the National Childhood Vaccine Injury Compensation Act.
The court, in affirming a Court of Appeals decision, held that a subsection of …
UPCOMING CONFERENCES
HarrisMartin's New Jersey Asbestos Litigation Conference
February 27, 2025 - New Brunswick, NJ
Hyatt Regency New Brunswick
HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation Conference
January 10, 2025 - Long Beach, CA
The Westin Long Beach